Benzo 3
Natural health product licensed in Canada
- Other names
- Bezo 2 Spray
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80050278
- Status
- Inactive licence
- Licence date
- 17 April 2014
- Revision date
- 18 May 2022
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 4-aminobenzoïque, Ester d'éthyle | 7.5 % |
Non-medicinal ingredients
(p)-hydroxybenzoate de propyl sodium, Benzoate de sodium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 mL ; maximum: 2 mL | 1 day |
Uses authorised in Canada
For reducing oversensitivity in advance of intercourse (US FDA 1992). For temporary male genital desensitisation, helping to slow the onset of ejaculation (US FDA 1992). Helps in temporarily retarding the onset of ejaculation/temporarily slowing the onset of ejaculation/temporarily prolonging the time until ejaculation (US FDA 1992). Helps in the prevention of premature ejaculation (US FDA 1992). Dose(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a health care practitioner (US FDA 1992). Keep out of reach of children. Store below 30 degree C.
- Contre-indications
If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use (HC 2011a, HC 2011B).
Source
Official Health Canada record, licence 80050278
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging